D-Index & Metrics Best Publications
Research.com 2022 Best Female Scientist Award Badge

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 111 Citations 40,998 917 World Ranking 2331 National Ranking 1365
Best female scientists D-index 112 Citations 42,065 1,397 World Ranking 481 National Ranking 297

Research.com Recognitions

Awards & Achievements

2022 - Research.com Best Female Scientist Award

Overview

What is she best known for?

The fields of study she is best known for:

  • Internal medicine
  • Cancer
  • Gene

Marina Konopleva focuses on Cancer research, Leukemia, Internal medicine, Myeloid leukemia and Apoptosis. Her Cancer research research is multidisciplinary, incorporating perspectives in Protein kinase B, Cell growth, Progenitor cell, Kinase and Programmed cell death. Her work carried out in the field of Leukemia brings together such families of science as Haematopoiesis, Stem cell and Bone marrow.

Her study in Internal medicine is interdisciplinary in nature, drawing from both Gastroenterology, Endocrinology, Surgery and Oncology. Her Myeloid leukemia study incorporates themes from Myeloid, Glycolysis, Venetoclax, Obatoclax and MAPK/ERK pathway. Marina Konopleva combines subjects such as Cell culture, Transcription factor and Mitochondrion with her study of Apoptosis.

Her most cited work include:

  • Mechanisms of apoptosis sensitivity and resistance to the BH3 mimetic ABT-737 in acute myeloid leukemia (850 citations)
  • Targetable Kinase-Activating Lesions in Ph-like Acute Lymphoblastic Leukemia (809 citations)
  • Venetoclax combined with decitabine or azacitidine in treatment-naive, elderly patients with acute myeloid leukemia. (676 citations)

What are the main themes of her work throughout her whole career to date?

Internal medicine, Cancer research, Myeloid leukemia, Leukemia and Oncology are her primary areas of study. Marina Konopleva has included themes like Gastroenterology and Surgery in her Internal medicine study. Her Cancer research study integrates concerns from other disciplines, such as Immunology, Bone marrow, Apoptosis and Stem cell.

Her Myeloid leukemia research is multidisciplinary, incorporating elements of Azacitidine, Refractory and Decitabine. In her study, Kinase is strongly linked to Protein kinase B, which falls under the umbrella field of Leukemia. Her biological study spans a wide range of topics, including Cancer, Chemotherapy, Transplantation and Lymphoblastic Leukemia.

She most often published in these fields:

  • Internal medicine (46.23%)
  • Cancer research (39.73%)
  • Myeloid leukemia (32.13%)

What were the highlights of her more recent work (between 2019-2021)?

  • Internal medicine (46.23%)
  • Myeloid leukemia (32.13%)
  • Oncology (26.81%)

In recent papers she was focusing on the following fields of study:

Her scientific interests lie mostly in Internal medicine, Myeloid leukemia, Oncology, Cancer research and Venetoclax. Her Internal medicine course of study focuses on Gastroenterology and Adverse effect. Her studies in Myeloid leukemia integrate themes in fields like Refractory, Myeloid, FLT3 Inhibitor, Leukemia and Hypomethylating agent.

As a member of one scientific family, she mostly works in the field of Oncology, focusing on Blinatumomab and, on occasion, Inotuzumab ozogamicin. The Cancer research study combines topics in areas such as Apoptosis, T cell, Mutant, Stem cell and Bone marrow. Her Venetoclax research incorporates elements of Cytarabine, Azacitidine, Combination therapy and Decitabine.

Between 2019 and 2021, her most popular works were:

  • Azacitidine and Venetoclax in Previously Untreated Acute Myeloid Leukemia (313 citations)
  • Molecular patterns of response and treatment failure after frontline venetoclax combinations in older patients with AML. (125 citations)
  • Advances in the Treatment of Acute Myeloid Leukemia: New Drugs and New Challenges. (64 citations)

In her most recent research, the most cited papers focused on:

  • Internal medicine
  • Cancer
  • Gene

Marina Konopleva spends much of her time researching Internal medicine, Venetoclax, Myeloid leukemia, Oncology and Cancer research. Her study in the field of Refractory, Cytarabine, Regimen and Hematopoietic stem cell transplantation is also linked to topics like In patient. Her research in Venetoclax intersects with topics in Myeloid, Azacitidine, Older patients and Decitabine.

Her Myeloid leukemia research focuses on Leukemia and how it relates to Intensive care medicine, Neutropenia, Progenitor cell, Dasatinib and Chemotherapy regimen. Her Oncology study combines topics in areas such as Clinical trial, Chemotherapy, Phases of clinical research, Newly diagnosed and Hypomethylating agent. Her Cancer research research is multidisciplinary, incorporating perspectives in Quizartinib, Apoptosis, Mutant and Bone marrow.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Targetable Kinase-Activating Lesions in Ph-like Acute Lymphoblastic Leukemia

K. G. Roberts;Y. Li;D. Payne-Turner;R. C. Harvey.
The New England Journal of Medicine (2014)

1013 Citations

Mechanisms of apoptosis sensitivity and resistance to the BH3 mimetic ABT-737 in acute myeloid leukemia

Marina Konopleva;Rooha Contractor;Twee Tsao;Ismael Samudio.
Cancer Cell (2006)

998 Citations

Venetoclax combined with decitabine or azacitidine in treatment-naive, elderly patients with acute myeloid leukemia.

Courtney D. DiNardo;Keith Pratz;Vinod Pullarkat;Brian A. Jonas.
Blood (2019)

709 Citations

Antidiabetic therapies affect risk of pancreatic cancer

Donghui Li;Sai–Ching J. Yeung;Manal M. Hassan;Marina Konopleva.
Gastroenterology (2009)

702 Citations

Pharmacologic inhibition of fatty acid oxidation sensitizes human leukemia cells to apoptosis induction

Ismael Samudio;Romain Harmancey;Michael Fiegl;Hagop Kantarjian.
Journal of Clinical Investigation (2010)

563 Citations

Efficacy and Biological Correlates of Response in a Phase II Study of Venetoclax Monotherapy in Patients with Acute Myelogenous Leukemia

Marina Konopleva;Daniel A. Pollyea;Jalaja Potluri;Brenda Chyla.
Cancer Discovery (2016)

537 Citations

Targeting the leukemia microenvironment by CXCR4 inhibition overcomes resistance to kinase inhibitors and chemotherapy in AML

Zhihong Zeng;Yue Xi Shi;Ismael J. Samudio;Rui Yu Wang.
Blood (2009)

530 Citations

Stromal cells prevent apoptosis of AML cells by up-regulation of anti-apoptotic proteins.

M Konopleva;S Konoplev;W Hu;AY Zaritskey.
Leukemia (2002)

446 Citations

Pegylated Interferon Alfa-2a Yields High Rates of Hematologic and Molecular Response in Patients With Advanced Essential Thrombocythemia and Polycythemia Vera

Alfonso Quintás-Cardama;Hagop Kantarjian;Taghi Manshouri;Rajyalakshmi Luthra.
Journal of Clinical Oncology (2009)

441 Citations

Selective BCL-2 Inhibition by ABT-199 Causes On-Target Cell Death in Acute Myeloid Leukemia

Rongqing Pan;Leah J. Hogdal;Juliana M. Benito;Donna Bucci.
Cancer Discovery (2014)

434 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Marina Konopleva

Hagop M. Kantarjian

Hagop M. Kantarjian

The University of Texas MD Anderson Cancer Center

Publications: 279

Jorge E. Cortes

Jorge E. Cortes

Augusta University

Publications: 200

Elias Jabbour

Elias Jabbour

The University of Texas MD Anderson Cancer Center

Publications: 161

Farhad Ravandi

Farhad Ravandi

The University of Texas MD Anderson Cancer Center

Publications: 137

Stephen Safe

Stephen Safe

Texas A&M University

Publications: 97

Guillermo Garcia-Manero

Guillermo Garcia-Manero

The University of Texas MD Anderson Cancer Center

Publications: 96

Michael Andreeff

Michael Andreeff

The University of Texas MD Anderson Cancer Center

Publications: 93

Srdan Verstovsek

Srdan Verstovsek

The University of Texas MD Anderson Cancer Center

Publications: 86

Charles G. Mullighan

Charles G. Mullighan

St. Jude Children's Research Hospital

Publications: 85

James A. McCubrey

James A. McCubrey

East Carolina University

Publications: 83

Gautam Borthakur

Gautam Borthakur

The University of Texas MD Anderson Cancer Center

Publications: 76

Giovanni Martinelli

Giovanni Martinelli

University of Bologna

Publications: 75

Richard Stone

Richard Stone

Harvard University

Publications: 73

Arnon Nagler

Arnon Nagler

Sheba Medical Center

Publications: 72

Susan O'Brien

Susan O'Brien

University of California, Irvine

Publications: 68

Mark J. Levis

Mark J. Levis

Johns Hopkins University

Publications: 65

Trending Scientists

Roberto Pieraccini

Roberto Pieraccini

Google (United States)

Babak Nahid-Mobarakeh

Babak Nahid-Mobarakeh

McMaster University

Scott J. Moura

Scott J. Moura

University of California, Berkeley

Qiang Su

Qiang Su

Sun Yat-sen University

Ken-ichi Harada

Ken-ichi Harada

Meijo University

Subhas C. Kundu

Subhas C. Kundu

University of Minho

Huntington F. Willard

Huntington F. Willard

Case Western Reserve University

Samuel N. Luoma

Samuel N. Luoma

University of California, Davis

Kenneth R. Boheler

Kenneth R. Boheler

Johns Hopkins University

Nicholas Christie-Blick

Nicholas Christie-Blick

Lamont-Doherty Earth Observatory

Daniel M. Ricciuto

Daniel M. Ricciuto

Oak Ridge National Laboratory

Christian C. Ruff

Christian C. Ruff

University of Zurich

Robert C. Green

Robert C. Green

Brigham and Women's Hospital

Leon J. Thal

Leon J. Thal

Veterans Health Administration

David N. Burrows

David N. Burrows

Pennsylvania State University

Something went wrong. Please try again later.